Related Experiment Video
Updated: Jul 7, 2026

Implantation of Electroencephalogram and Electrocardiogram Telemetry Devices in Neonatal Rabbit Kits
Published on: February 28, 2025
Intravenous clonidine infusion in infants after cardiovascular surgery
Anja Pohl-Schickinger1, Julia Lemmer, Michael Hübler
1Department of Neonatology, University Hospital Charité, Berlin, Germany. anja.pohl@charite.de
Insights
Intravenous clonidine infusion in infants after cardiac surgery is feasible, maintaining hemodynamic stability and normal heart rhythm without adverse effects. This off-label use can help reduce withdrawal symptoms and allow for opioid discontinuation.
Area of Science:
- Pediatric Cardiology
- Pediatric Critical Care Medicine
- Pharmacology
Background:
- Infants undergoing cardiac surgery often require prolonged analgesia and sedation.
- Withdrawal symptoms like CNS hyperactivation, hypertension, and tachycardia are common post-surgery.
- Managing these symptoms is crucial for hemodynamic stability.
Purpose of the Study:
- To investigate the hemodynamic profile and heart rhythm in infants receiving intravenous clonidine infusion.
- To assess the safety and efficacy of clonidine for sedation and withdrawal symptom management post-cardiac surgery.
- To evaluate the potential for opioid discontinuation during clonidine treatment.
Main Methods:
- Single center retrospective review of 50 infants (0-24 months) undergoing cardiovascular surgery.
- Clonidine infusion (0.18-3.6 microg.kg(-1).h(-1)) administered for sedation and withdrawal symptom reduction.
- Analysis of hospital records for hemodynamic parameters, heart rhythm, and adverse effects.
Main Results:
- Clonidine infusion normalized hemodynamic parameters, reducing heart rate and mean arterial pressure within 24 hours (P < 0.001).
- No instances of hypotension requiring additional therapy or adverse effects on cardiac rhythm, including atrioventricular block, were observed.
- Opioid medications (Midazolam, fentanyl) were successfully discontinued by day 4 of clonidine treatment.
Conclusions:
- Intravenous clonidine infusion is a feasible off-label option for infants in the Pediatric Intensive Care Unit (PICU) post-cardiac surgery.
- Clonidine effectively manages hemodynamic parameters and withdrawal symptoms without causing hemodynamic instability or cardiac rhythm issues.
- This approach facilitates opioid weaning and supports overall patient recovery.
Background:
The aim of this study was to investigate the hemodynamic profile and heart rhythm in infants who were given intravenous clonidine infusion after prolonged analgesia/sedation following cardiac surgery.
Methods:
This is a single center retrospective review. A total of 542 cardiovascular surgical procedures in infants aged 0-24 months with congenital heart disease were performed between 01/2003 and 12/2005 at the Deutsches Herzzentrum in Berlin. The majority received no long-term analgesia/sedation, but 50 (9%) of these infants received clonidine (dosed at 0.18-3.6 microg.kg(-1).h(-1)) for sedation and to reduce withdrawal symptoms such as CNS hyperactivation, hypertension, tachycardia, and fever. The hospital records of these infants were studied.
Results:
Fifty infants (median age 5.0 months, median body weight 5.3 kg, 32 males/18 females) received prolonged analgesia/sedation to ensure hemodynamic stability. Clonidine infusion started on day 5 (median) after surgery. During clonidine treatment we found an age-related normalized profile of hemodynamic parameters with a reduction of heart rate and mean arterial pressure from the upper norm to the mean within 24 h (P < 0.001). In no case did clonidine cause low blood pressure resulting in additional therapy to reach the target blood pressure. There were no adverse effects on cardiac rhythm, especially no onset of atrioventricular block. Midazolam, fentanyl, and other opioids could be ended on day 4 of clonidine treatment.
Conclusions:
Although off-label, it is feasible to use clonidine infusions in infants in the PICU setting after cardiac surgery without hemodynamic problems arising.
More Related Videos
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiac Catheterization IV: Nursing Management
Drug Dosing: Infants and Children
Parenteral Anesthetics: Overview
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

